Stifel Maintains Buy on Insulet, Lowers Price Target to $180

Benzinga Newsdesk www.benzinga.com Negative 85.7%

Neg 85.7% Neu 0% Pos 0%

Stifel analyst Jonathan Block maintains Insulet (NASDAQ:PODD) with a Buy and lowers the price target from $225 to $180.

Comments

No comments yet. Be the first!